Coronary in-stent restenosis

被引：0

作者：

张金国 ^{[1
]}

刘洪岩 ^{[2
]}

廖玉华 ^{[3
]}

机构：

[1] Department of Cardiology,Affiliated Hospital of Jining Medical College, Key Lab of Heart Disease Diagnose and Treatment in Shandong Province

[2] Department of Cardiology, The people's Hospital of Laiwu City

[3] Institute of Cardiology, Union Hospital,Tongji Medical College of Huazhong University of Science and Technology

来源：

SouthChinaJournalofCardiology | 2012年 / 13卷 / 02期

关键词：

coronary revascularization; coronary stent implantation; drug-eluting stent; restenosis; rate;

D O I：

10.16268/j.cnki.44-1512/r.2012.02.010

中图分类号：

R541.4 [冠状动脉（粥样）硬化性心脏病（冠心病）];

学科分类号：

1002 ; 100201 ;

摘要：

Coronary stent implantation was considered as a way of coronary revascularization. It has been widely used in the treatment of coronary heart disease, but restenosis has become the main bottleneck to the development of stent technique. Despite drug-eluting stents used widely, restenosis rate is still about 10%. The incidence of restenosis was associated with intervention injury, patient factors, genetic types, nerve endocrine factors and so on. Overview above aspects is expected to provide some ideas for restenosis prevention and treatment.

引用

页码：127 / 133

页数：7

共 13 条

[1] 整合素与冠脉介入治疗后再狭窄 [J].

胡文兰 ;

乔树宾 .

心血管病学进展, 2007, (03) :389-392

[2] Exploring the molecular mechanisms of OSU-03012 on vascular smooth muscle cell proliferation [J].

Wei-Wen Kuo ;

Jing-Ru Weng ;

Chih-Yang Huang ;

Chang-Hai Tsai ;

Wei-Hung Liu ;

Cheng-Hao Wen ;

Shih-Chang Tsai ;

Chieh-Hsi Wu .

Molecular and Cellular Biochemistry, 2010, 344 :81-89

[3] Interleukin 8 gene polymorphisms and susceptibility to restenosis after percutaneous coronary intervention [J].

Vogiatzi, Konstantina ;

Apostolakis, Stavros ;

Voudris, Vassilis ;

Thomopoulou, Sofia ;

Kochiadakis, Georgios E. ;

Spandidos, Demetrios A. .

JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2010, 29 (01) :134-140

[4]

p27kip1–838C>A Single Nucleotide Polymorphism Is Associated With Restenosis Risk After Coronary Stenting and Modulates p27kip1 Promoter Activity[J] . Claudia M. van Tiel,Peter I. Bonta,Saskia Z.H. Rittersma,Marcel A.M. Beijk,Edward J. Bradley,Anita M. Klous,Karel T. Koch,Frank Baas,J Wouter Jukema,Douwe Pons,M Lourdes Sampietro,Hans Pannekoek,Robbert J. de Winter,Carlie J.M. de Vries.Circulation . 2009 (8)

[5]

Tumor Necrosis Factor Alpha and Interleukin 10 Promoter Polymorphisms in Mexican Patients with Restenosis After Coronary Stenting[J] . Biochemical Genetics . 2009 (9)

[6] THE ROLE OF INTERLEUKIN-6 AND TRANSFORMING GROWTH FACTOR-β1 IN PREDICTING RESTENOSIS WITHIN STENTED INFARCT-RELATED ARTERY [J].

Szkodzinski, J. ;

Blazelonis, A. ;

Wilczek, K. ;

Hudzik, B. ;

Romanowski, W. ;

Gasior, M. ;

Wojnar, R. ;

Lekston, A. ;

Polonski, L. ;

Zubelewicz-Szkodzinska, B. .

INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY, 2009, 22 (02) :493-500

[7]

Low basal levels of circulating adiponectin in patients undergoing coronary stenting predict in-stent restenosis, independently of basal levels of inflammatory markers: Lipoprotein associated phospholipase A2, and myeloperoxidase[J] . Elena Moldoveanu,Bogdan Mut-Vitcu,George R. Tanaseanu,Daciana S. Marta,Gabriela Manea,Tetsuya Kosaka,Cristina Vidulescu,Cristina Tanaseanu.Clinical Biochemistry . 2008 (18)

[8] Impact of plasma aldosterone levels for prediction of in-stent-restenosis [J].